|
| | 09900SB2403sam001 | - 2 - | LRB099 18409 MJP 45732 a |
|
|
1 | | (210 ILCS 85/6.23a new) |
2 | | Sec. 6.23a. Sepsis screening protocols. |
3 | | (a) Each hospital shall adopt, implement, and periodically |
4 | | update evidence-based protocols for the early recognition and |
5 | | treatment of patients with sepsis, severe sepsis, or septic |
6 | | shock (sepsis protocols) that are based on generally accepted |
7 | | standards of care. Sepsis protocols must include components |
8 | | specific to the identification, care, and treatment of adults |
9 | | and of children, and must clearly identify where and when |
10 | | components will differ for adults and for children seeking |
11 | | treatment in the emergency department or as an inpatient. These |
12 | | protocols must also include the following components: |
13 | | (1) a process for the screening and early recognition |
14 | | of patients with sepsis, severe sepsis, or septic shock; |
15 | | (2) a process to identify and document individuals |
16 | | appropriate for treatment through sepsis protocols, |
17 | | including explicit criteria defining those patients who |
18 | | should be excluded from the protocols, such as patients |
19 | | with certain clinical conditions or who have elected |
20 | | palliative care; |
21 | | (3) guidelines for hemodynamic support with explicit |
22 | | physiologic and treatment goals, methodology for invasive |
23 | | or non-invasive hemodynamic monitoring, and timeframe |
24 | | goals; |
25 | | (4) for infants and children, guidelines for fluid |
26 | | resuscitation consistent with current, evidence-based |
|
| | 09900SB2403sam001 | - 3 - | LRB099 18409 MJP 45732 a |
|
|
1 | | guidelines for severe sepsis and septic shock with defined |
2 | | therapeutic goals for children; |
3 | | (5) identification of the infectious source and |
4 | | delivery of early broad spectrum antibiotics with timely |
5 | | re-evaluation to adjust to narrow spectrum antibiotics |
6 | | targeted to identified infectious sources; and |
7 | | (6) criteria for use, based on accepted evidence of |
8 | | vasoactive agents. |
9 | | (b) Each hospital shall ensure that professional staff with |
10 | | direct patient care responsibilities and, as appropriate, |
11 | | staff with indirect patient care responsibilities, including, |
12 | | but not limited to, laboratory and pharmacy staff, are |
13 | | periodically trained to implement the sepsis protocols |
14 | | required under subsection (a). The hospital shall ensure |
15 | | updated training of staff if the hospital initiates substantive |
16 | | changes to the sepsis protocols. |
17 | | (c) Each hospital shall be responsible for the collection |
18 | | and utilization of quality measures related to the recognition |
19 | | and treatment of severe sepsis for purposes of internal quality |
20 | | improvement. |
21 | | (d) The evidence-based protocols adopted under this |
22 | | Section shall be provided to the Department upon the |
23 | | Department's request. |
24 | | (e) Hospitals submitting sepsis data as required by the |
25 | | Center for Medicare and Medicaid Services Hospital Inpatient |
26 | | Quality Reporting program as of fiscal year 2016 are presumed |
|
| | 09900SB2403sam001 | - 4 - | LRB099 18409 MJP 45732 a |
|
|
1 | | to meet the sepsis protocol requirements outlined in this |
2 | | Section. |
3 | | (f) Subject to appropriation, the Department shall: |
4 | | (1) recommend evidence-based sepsis definitions and |
5 | | metrics that incorporate evidence-based findings, |
6 | | including appropriate antibiotic stewardship, and that |
7 | | align with the National Quality Forum, the Centers for |
8 | | Medicare and Medicaid Services, the Agency for Healthcare |
9 | | Research and Quality, and The Joint Commission; |
10 | | (2) establish and use a methodology for collecting, |
11 | | analyzing, and disclosing the information collected under |
12 | | this Section, including collection methods, formatting, |
13 | | and methods and means for aggregate data release and |
14 | | dissemination; |
15 | | (3) complete a digest of efforts and recommendations no |
16 | | later than 12 months after the effective date of this |
17 | | amendatory Act of the 99th General Assembly; the digest may |
18 | | include Illinois-specific data, trends, conditions, or |
19 | | other clinical factors; a summary shall be provided to the |
20 | | Governor and General Assembly and shall be publicly |
21 | | available on the Department's website; and |
22 | | (4) consult and seek input and feedback prior to the |
23 | | proposal, publication, or issuance of any guidance, |
24 | | methodologies, metrics, rulemaking, or any other |
25 | | information authorized under this Section from statewide |
26 | | organizations representing hospitals, physicians, advanced |
|
| | 09900SB2403sam001 | - 5 - | LRB099 18409 MJP 45732 a |
|
|
1 | | practice nurses, pharmacists, and long-term care |
2 | | facilities. Public and private hospitals, epidemiologists, |
3 | | infection prevention professionals, health care |
4 | | informatics and health care data professionals, and |
5 | | academic researchers may be consulted. |
6 | | If the Department receives an appropriation and carries out |
7 | | the requirements of paragraphs (1), (2), (3), and (4), then the |
8 | | Department may adopt rules concerning the collection of data |
9 | | from hospitals regarding sepsis and requiring that each |
10 | | hospital shall be responsible for reporting to the Department. |
11 | | Any publicly released hospital-specific information under |
12 | | this Section is subject to data provisions specified in Section |
13 | | 25 of the Hospital Report Card Act.
|
14 | | Section 99. Effective date. This Act takes effect upon |
15 | | becoming law.".
|